arrow
Y

Ying Sun

Guangdong Provincial Clinical Research Center for Cancer
H指数:81
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study

局部晚期鼻咽癌辅助性口服卡培他滨的长期疗效:一项随机对照多中心III期研究

2026-06-300
PRE
MedNext-Insight Model for Automated Metabolic Tumor Volume Delineation on Computed Tomography and Prognostic Value in Nasopharyngeal Carcinoma

MedNext-Insight模型在计算机断层扫描中的代谢肿瘤体积自动勾画及在鼻咽癌中的预后价值

2026-05-160
PRE
Nasopharyngeal carcinoma screening using Epstein–Barr virus Cp methylation triage in two population-based screening cohorts

鼻咽癌筛查:利用Epstein–Barr病毒Cp甲基化在两个基于人群的筛查队列中的分层策略

2026-04-220
OAAI
Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy

鼻咽癌的多组学表征明确了诱导化疗反应的亚型特异性景观

2026-04-150
PRE
A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair in Alzheimer's Disease-Like Non-Human Primate Model

基于NeuroD1 AAV的基因疗法在阿尔茨海默病样非人灵长类模型中的功能性脑修复

2026-03-100
OAAI
Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China

伊布替尼与三个周期的间歇氟达拉滨、环磷酰胺和利妥昔单抗(FCR)交替用于初治慢性淋巴细胞白血病的成人患者,作为限时方案:一项在中国进行的单臂、多中心II期试验

2025-12-050
OAAI
Overcoming EGFR-Mediated Dendritic Cell Dysfunction to Enhance Anti-tumor Immunity in EGFR-Mutant NSCLC by Precisely Targeting CD73 With pH-responsive Nanocarriers

通过精准靶向CD73的pH响应性纳米载体克服EGFR介导的树突状细胞功能障碍,以增强EGFR突变型NSCLC的抗肿瘤免疫。

2025-10-270
OAAI
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas

鼻咽癌放射治疗中的大体肿瘤靶区勾画:CSTRO、CACA、CSCO、HNCIG、ESTRO和ASTRO指南及勾画图谱

2025-09-010
PRE
Tissue-resident microbiota signature in nasopharyngeal carcinoma

鼻咽癌中组织驻留微生物组特征

2025-05-170
OA